Prokidney Corp Stock In The News

PROK Stock  USD 1.67  0.12  6.70%   
Our overall analysis of ProKidney Corp's news coverage and content from conventional and social sources shows investors' bearish mood towards ProKidney Corp. The specific impact of ProKidney Corp news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of ProKidney Corp's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using ProKidney Corp headlines in addition to utilizing other, more conventional financial analysis modules. Check out ProKidney Corp Backtesting and ProKidney Corp Hype Analysis.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

ProKidney Corp Today Top News and Investor Outlook

Yahoo News
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference
https://finance.yahoo.com/news/prokidney-present-43rd-annual-j-123000293.html
 Neutral
Yahoo News
One ProKidney Insider Raised Their Stake In The Previous Year
https://finance.yahoo.com/news/one-prokidney-insider-raised-stake-125643660.html
 Bullish
Yahoo News
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
https://finance.yahoo.com/news/prokidney-participate-two-upcoming-conferences-123000851.html
 Neutral
Yahoo News
US Penny Stocks To Watch: 3 Picks With Market Caps Under $500M
https://finance.yahoo.com/news/us-penny-stocks-watch-3-000916790.html
 Bullish
Yahoo News
ProKidney Reports Third Quarter 2024 Fin...
https://finance.yahoo.com/news/prokidney-reports-third-quarter-2024-123000860.html
 Bullish
Yahoo News
ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference
https://finance.yahoo.com/news/prokidney-participate-guggenheim-inaugural-healthcare-123000579.html
 Neutral
Yahoo News
Suvretta Capital Management's Strategic Acquisition in ProKidney Corp
https://finance.yahoo.com/news/suvretta-capital-managements-strategic-acquisition-230240820.html
 Bullish
Yahoo News
We're Not Very Worried About ProKidney's (NASDAQ:PROK) Cash Burn Rate
https://finance.yahoo.com/news/were-not-very-worried-prokidneys-152558045.html
 Neutral
Yahoo News
ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024
https://finance.yahoo.com/news/prokidney-announces-five-abstracts-selected-113000593.html
 Neutral
Yahoo News
ProKidney to Participate in the UBS Virtual Organ Restoration Day
https://finance.yahoo.com/news/prokidney-participate-ubs-virtual-organ-113000719.html
 Neutral

ProKidney Corp Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ProKidney and other traded companies coverage with news coverage. We help investors stay connected with ProKidney headlines for the 22nd of January to make an informed investment decision based on correlating the impacts of news items on ProKidney Stock performance. Please note that trading solely based on the ProKidney Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
ProKidney Corp's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help ProKidney Corp investors visualize upcoming and past events in order to time the market based on ProKidney Corp noise-free hype analysis.
ProKidney Corp stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ProKidney earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about ProKidney Corp that are available to investors today. That information is available publicly through ProKidney media outlets and privately through word of mouth or via ProKidney internal channels. However, regardless of the origin, that massive amount of ProKidney data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ProKidney Corp news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProKidney Corp relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProKidney Corp's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProKidney Corp alpha.

ProKidney Largest EPS Surprises

Earnings surprises can significantly impact ProKidney Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-10
2024-03-31-0.18-0.160.0211 
2023-11-14
2023-09-30-0.16-0.18-0.0212 
2024-03-22
2023-12-31-0.17-0.090.0847 
2022-11-14
2022-09-30-0.24-0.130.1145 
2023-03-28
2022-12-31-0.24-0.110.1354 
2023-05-11
2023-03-31-0.39-0.160.2358 
View All Earnings Estimates

ProKidney Corp Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to ProKidney Corp Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
7th of January 2025
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference
at gurufocus.com 
bizjournals News
2nd of January 2025
Stories to Watch in 2025 Will ProKidney change its Winston-Salem plans after abandoning 45...
at bizjournals.com 
Google News at Macroaxis
26th of December 2024
ProKidney Stock Price Down 2.5 percent - Heres What Happened - MarketBeat
at news.google.com 
Yahoo News
26th of November 2024
ProKidney to Participate in Two Upcoming Conferences Evercore HealthCONx Conference and th...
at finance.yahoo.com 
bizjournals News
19th of November 2024
ProKidney Manufacturing expansion moving to W-S instead of GSO,
at bizjournals.com 
news
15th of November 2024
ProKidney Shares Up 7.8 percent Heres What Happened
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
8th of November 2024
Morgan Stanleys Strategic Reduction in ProKidney Corp Holdings
at gurufocus.com 
Yahoo News
5th of November 2024
Disposition of 137000 shares by Darin Weber of ProKidney Corp subject to Rule 16b-3
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ProKidney Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ProKidney Corp's short interest history, or implied volatility extrapolated from ProKidney Corp options trading.
When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:
Check out ProKidney Corp Backtesting and ProKidney Corp Hype Analysis.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Return On Assets
(0.20)
Return On Equity
(0.31)
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.